Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study

JOURNAL ARTICLE published 2023 in Journal of Korean Medical Science

Research funded by National Research Foundation of Korea (NRF-2019R1A2C1009923,NRF-2022R1A2B5B01001430) | Korean College of Helicobacter and Upper Gastrointestinal Research (KCHUGR – 202002001) | Dong-A Pharmaceutical Co. (0620211010)

Authors: Bokyung Kim | Jin-Hyung Jung | Kyungdo Han | Seungkyung Kang | Eunwoo Lee | Hyunsoo Chung | Sang Gyun Kim | Soo-Jeong Cho